Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
76 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 6 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more funds holding
Funds holding: 75 → 76 (+1)
5% less capital invested
Capital invested by funds: $143M → $135M (-$7.78M)
34% less call options, than puts
Call options by funds: $2.91M | Put options by funds: $4.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.56M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.67M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$918K |
| 4 |
DM
Deerfield Management
New York
|
+$650K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$600K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$793K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$278K |
| 3 |
Goldman Sachs
New York
|
-$215K |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
-$153K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$151K |
IMMU Hedge Fund Activity: Q2 2014 in Review
76 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2014, worth a combined $135M — down 5.4% from $143M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IMMU positions and 6 closed out — a net gain of 1 holder — while 32 added to existing stakes and 18 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.56M. The largest seller was Wellington Management Group, exiting entirely with an estimated $793K sold.
- 76 institutional investors held Immunomedics Inc (IMMU) as of Q2 2014, up from 75 in Q1 2014.
- Funds reported $135M of Immunomedics Inc stock for Q2 2014, down 5.4% quarter-over-quarter.
- 7 funds opened new Immunomedics Inc positions in Q2 2014 and 6 closed out, a net change of +1 holder.
- The largest Immunomedics Inc buyer in Q2 2014 was Fidelity Investments, an estimated $4.56M added.
- The largest Immunomedics Inc seller in Q2 2014 was Wellington Management Group, an estimated $793K sold.
Based on aggregated 13F filings for Q2 2014.